ARCHIVES

ASCO Annual Meeting: PARP Inhibitors Show Promise Against Breast Cancer In Small Phase II Studies

This article is from The Cancer Letter archive.

Vol. 35 No. 22 | June 5, 2009

Download PDF Visit The Full Archive

Related Articles

In Brief: Breast Cancer Projects To Pay For Concurrent Pathology Review; Laetrile Study Entry Closed

May 19, 1978

Cancer Genome Atlas Researchers Link Cell Metabolism Pathways To Disease Aggressiveness

July 26, 2013

Loeb Named ACS President, Eyre President Elect

November 14, 1986

Phase III Regorafenib Trial Meets PFS Primary Endpoint

June 29, 2012

NCI Decides To Accept NCAB Recommendation, Award Organ Systems Coordinating Center to Roswell Park

July 6, 1984

NCAB Sets Bypass Budget Figures at $1.074 Billion

May 28, 1982